Vibrant Therapeutics

Precise Treatments. Real-World Impact.

Vibrant Therapeutics was founded in 2019, is headquartered in Guangzhou, China, lists 11–50 employees, and has $61.0M in recorded funding across 2 rounds.

Headquarters
Guangzhou
Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$61.0M
Last Round
$61.0M Series BJan 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 6 investors for this company. The full record is or through the API.

About

Vibrant Therapeutics is a clinical-stage biotechnology company developing intelligent, logic-gated therapeutics designed to selectively activate in the desired disease microenvironment. Founded in 2019 by Dr. Larry Wang, Ph.D. (co-founder of GenScript), the company leverages an integrated computational and experimental (dry-wet) R&D platform to advance a pipeline of first-in-class and best-in-class programs. Its lead program, VIB305, is a logic-gated, masked T-cell engager (TCE) prodrug targeting EGFR-positive solid tumors, which has received US FDA IND acceptance and is in Phase 1 clinical trials in Australia, China, and the US. The company's proprietary BumbleBee, LogicBee, and NeuroBee platforms combine advanced computing with multi-specific antibody engineering to design safer, more effective biotherapeutics for oncological, autoimmune, and neurological diseases. Vibrant has raised over $100 million in total funding, including a $61 million round backed by Pfizer Ventures and Apricot Capital, and is headquartered in Guangzhou, China with a US presence in Cambridge, Massachusetts.

Summary

Vibrant Therapeutics is a Biotech company based in Guangzhou, China, founded in 2019. It lists 11–50 employees. It has raised $61.0M in total across 2 rounds, most recently a $61.0M Series B round in Jan 2026. Investors include Pfizer Ventures, Apricot Capital and Trinity Innovation Bioventure Singapore.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJan 2026
$61.0M

Sign up to see all 2 events

Funding: Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Vibrant Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/vibrant-therapeutics"><img src="https://indexed.vc/api/badge/company/vibrant-therapeutics" alt="Vibrant Therapeutics on Indexed.vc" width="260" height="76" /></a>